The Fight Against COVID-19 Needs The Real-World Data Now Available To Researchers Worldwide

By Dan O’Connor, SVP, Growth, Ciox Real World Data

With the resurgent spread of COVID-19 through American communities nationwide comes an explosion of COVID-19 data as a byproduct; real-world data (RWD) necessary and useful to accelerate containment, tracing, and treatment solutions. But to access the intelligence within the data, our industry must step up in the proliferation of innovative data-driven solutions.

An Explosion of COVID-19 Data

Coronavirus is on the rise once more. With each positive (and negative) test, every interaction of care with a professional, every hospital visit, every ICU admission, and sadly, every death comes vast amounts of clinical data captured at the various points of care.

That care information is the raw form of real-world COVID-19 data, all of it, and every line on every chart represents the exact data point at which researchers and clinicians could begin to understand the critical characteristics of the novel coronavirus. The data is how we will power understanding to develop therapies, provide clinical guidance, and build containment strategies.

Significant insights will come when organizations gain access and can deep-dive into the aggregate COVID-19 RWD dataset. Gathering and distributing that data has been the order of the day for organizations like Ciox Real World Data and others in health data. As more and more meaningful data reaches the hands of researchers and analysts, key learnings that solve important COVID-19 questions may be right around the next corner.